These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33176137)

  • 21. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor genetic heterogeneity].
    Yang YL; Chu JY; Wang MR
    Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating human cancer cell metastasis in zebrafish.
    Teng Y; Xie X; Walker S; White DT; Mumm JS; Cowell JK
    BMC Cancer; 2013 Oct; 13():453. PubMed ID: 24089705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic insights into the morass of metastatic heterogeneity.
    Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
    Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.
    Kuo CC; Ling HH; Chiang MC; Chung CH; Lee WY; Chu CY; Wu YC; Chen CH; Lai YW; Tsai IL; Cheng CH; Lin CW
    Theranostics; 2019; 9(9):2526-2540. PubMed ID: 31131051
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.
    Andrechek ER; Cardiff RD; Chang JT; Gatza ML; Acharya CR; Potti A; Nevins JR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16387-92. PubMed ID: 19805309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells.
    Pierre M; DeHertogh B; Gaigneaux A; DeMeulder B; Berger F; Bareke E; Michiels C; Depiereux E
    BMC Cancer; 2010 Apr; 10():176. PubMed ID: 20433688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
    Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
    Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.
    Tellez-Gabriel M; Ory B; Lamoureux F; Heymann MF; Heymann D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells.
    Luo C; Shu Y; Luo J; Liu D; Huang DS; Han Y; Chen C; Li YC; Zou JM; Qin J; Wang Y; Li D; Wang SS; Zhang GM; Chen J; Feng ZH
    Oncogene; 2017 May; 36(20):2889-2899. PubMed ID: 28092676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.
    Suzuki S; Sato M; Senoo H; Ishikawa K
    Exp Cell Res; 2004 Feb; 293(2):259-66. PubMed ID: 14729463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
    Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
    Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
    Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
    Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.